14-3-3 protein is a component of Lewy bodies in Parkinson’s disease—Mutation analysis and association studies of 14-3-3 eta
Andreas Ubl(University of Rostock), Olaf Rieß(University of Tübingen), Klaus Berger(University of Münster), Antje Bornemann(University Children's Hospital Tübingen), Thomas Arzberger(Ludwig-Maximilians-Universität München), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Rejko Krüger(Centre Hospitalier de Luxembourg), Carsten Holzmann(University of Rostock)
Cited by 62
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k